Osiris Therapeutics Inc. | Mutual Funds
Mutual Funds that own Osiris Therapeutics Inc.
HealthInvest Micro Cap Fund
1,140,222
3.3%
1,140,222
6.8%
06/30/2017
1,130,000
3.27%
0
15.02%
03/31/2018
John Hancock - Small Cap Core Fund
192,318
0.56%
183,171
0.94%
01/31/2018
Gabelli Healthcare & Wellness Trust
160,000
0.46%
160,000
0.42%
06/30/2018
Gabelli Asset Fund (The)
50,000
0.14%
50,000
0.02%
06/30/2018
Manulife Global Fund - US Small Cap Equity Fund
23,890
0.07%
23,890
0.71%
12/31/2017
RZ Star Fonds
23,000
0.07%
-14,000
4.93%
03/26/2018
RZ Basis Fonds
19,000
0.06%
-1,000
3.29%
03/26/2018
Kinetics Medical Portfolio
19,000
0.06%
-2,000
1.02%
06/29/2018
Gabelli Global Small & Mid Cap Value Trust (The)
17,500
0.05%
17,500
0.09%
06/30/2018
Illinois State Board of Investment
1,550
0%
-3,850
0%
06/30/2016
| Address |
7015 Albert Einstein Drive
Columbia Maryland 21046
United States
|
|
Employees
|
- |
| Website |
http://www.osiris.com |
| Updated |
09/14/2018 |
| Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. The company was founded by Peter A. |
